These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

385 related items for PubMed ID: 15545356

  • 1. NKG2D recognition and perforin effector function mediate effective cytokine immunotherapy of cancer.
    Smyth MJ, Swann J, Kelly JM, Cretney E, Yokoyama WM, Diefenbach A, Sayers TJ, Hayakawa Y.
    J Exp Med; 2004 Nov 15; 200(10):1325-35. PubMed ID: 15545356
    [Abstract] [Full Text] [Related]

  • 2. NKG2D function protects the host from tumor initiation.
    Smyth MJ, Swann J, Cretney E, Zerafa N, Yokoyama WM, Hayakawa Y.
    J Exp Med; 2005 Sep 05; 202(5):583-8. PubMed ID: 16129707
    [Abstract] [Full Text] [Related]

  • 3. NK cells use NKG2D to recognize a mouse renal cancer (Renca), yet require intercellular adhesion molecule-1 expression on the tumor cells for optimal perforin-dependent effector function.
    Abdool K, Cretney E, Brooks AD, Kelly JM, Swann J, Shanker A, Bere EW, Yokoyama WM, Ortaldo JR, Smyth MJ, Sayers TJ.
    J Immunol; 2006 Aug 15; 177(4):2575-83. PubMed ID: 16888019
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B.
    Gastroenterology; 2006 Feb 15; 130(2):435-52. PubMed ID: 16472598
    [Abstract] [Full Text] [Related]

  • 5. NKG2D and cytotoxic effector function in tumor immune surveillance.
    Hayakawa Y, Smyth MJ.
    Semin Immunol; 2006 Jun 15; 18(3):176-85. PubMed ID: 16675266
    [Abstract] [Full Text] [Related]

  • 6. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W, Osaki T, Okamura H, Robbins PD, Kurimoto M, Nagata S, Lotze MT, Tahara H.
    J Immunol; 1999 Jul 15; 163(2):583-9. PubMed ID: 10395644
    [Abstract] [Full Text] [Related]

  • 7. Cutting edge: tumor rejection mediated by NKG2D receptor-ligand interaction is dependent upon perforin.
    Hayakawa Y, Kelly JM, Westwood JA, Darcy PK, Diefenbach A, Raulet D, Smyth MJ.
    J Immunol; 2002 Nov 15; 169(10):5377-81. PubMed ID: 12421908
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C, Zhang J, Niu J, Zhou Z, Zhang J, Tian Z.
    Hum Immunol; 2008 Aug 15; 69(8):490-500. PubMed ID: 18619507
    [Abstract] [Full Text] [Related]

  • 9. IL-2/IL-18 prevent the down-modulation of NKG2D by TGF-beta in NK cells via the c-Jun N-terminal kinase (JNK) pathway.
    Song H, Hur DY, Kim KE, Park H, Kim T, Kim CW, Bang S, Cho DH.
    Cell Immunol; 2006 Jul 15; 242(1):39-45. PubMed ID: 17070508
    [Abstract] [Full Text] [Related]

  • 10. Expression and function of TNF-related apoptosis-inducing ligand on murine activated NK cells.
    Kayagaki N, Yamaguchi N, Nakayama M, Takeda K, Akiba H, Tsutsui H, Okamura H, Nakanishi K, Okumura K, Yagita H.
    J Immunol; 1999 Aug 15; 163(4):1906-13. PubMed ID: 10438925
    [Abstract] [Full Text] [Related]

  • 11. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.
    Nat Immunol; 2000 Aug 15; 1(2):119-26. PubMed ID: 11248803
    [Abstract] [Full Text] [Related]

  • 12. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.
    J Immunol; 1998 Oct 15; 161(8):3957-65. PubMed ID: 9780164
    [Abstract] [Full Text] [Related]

  • 13. Acidic pH inhibits non-MHC-restricted killer cell functions.
    Fischer B, Müller B, Fischer KG, Baur N, Kreutz W.
    Clin Immunol; 2000 Sep 15; 96(3):252-63. PubMed ID: 10964544
    [Abstract] [Full Text] [Related]

  • 14. T cells gene-engineered with DAP12 mediate effector function in an NKG2D-dependent and major histocompatibility complex-independent manner.
    Teng MW, Kershaw MH, Hayakawa Y, Cerutti L, Jane SM, Darcy PK, Smyth MJ.
    J Biol Chem; 2005 Nov 18; 280(46):38235-41. PubMed ID: 16169855
    [Abstract] [Full Text] [Related]

  • 15. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 18; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 16. Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function.
    Roda-Navarro P, Vales-Gomez M, Chisholm SE, Reyburn HT.
    Proc Natl Acad Sci U S A; 2006 Jul 25; 103(30):11258-63. PubMed ID: 16849432
    [Abstract] [Full Text] [Related]

  • 17. Chimeric NKG2D modified T cells inhibit systemic T-cell lymphoma growth in a manner involving multiple cytokines and cytotoxic pathways.
    Zhang T, Barber A, Sentman CL.
    Cancer Res; 2007 Nov 15; 67(22):11029-36. PubMed ID: 18006849
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-12 up-regulates perforin- and Fas-mediated lymphokine-activated killer activity by intestinal intraepithelial lymphocytes.
    Ebert EC.
    Clin Exp Immunol; 2004 Nov 15; 138(2):259-65. PubMed ID: 15498035
    [Abstract] [Full Text] [Related]

  • 19. Sequential activation of NKT cells and NK cells provides effective innate immunotherapy of cancer.
    Smyth MJ, Wallace ME, Nutt SL, Yagita H, Godfrey DI, Hayakawa Y.
    J Exp Med; 2005 Jun 20; 201(12):1973-85. PubMed ID: 15967825
    [Abstract] [Full Text] [Related]

  • 20. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12.
    Homma S, Komita H, Sagawa Y, Ohno T, Toda G.
    Immunology; 2005 Aug 20; 115(4):451-61. PubMed ID: 16011514
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.